Preparation and Characterization of Dutasteride Nanoparticles as Oral Fast-Dissolving Film

Rusul W.  Kadhum; Shaimaa N.  Abd-Alhammid

doi:10.32007/jfacmedbagdad.6622240

المؤلفون

Rusul W. Kadhum Department of Pharmaceutics, College of Pharmacy, University of Babylon, Babylon, Iraq. https://orcid.org/0009-0006-2258-6649
Shaimaa N. Abd-Alhammid Department of Pharmaceutics, College of Pharmacy, University of Baghdad, Baghdad, Iraq. https://orcid.org/0009-0007-3935-1245

DOI:

https://doi.org/10.32007/jfacmedbagdad.6622240

الكلمات المفتاحية:

Benign prostatic hyperplasia، Dutasteride، Oral films، Polymers، Solvent casting، Solvent antisolvent precipitation.

الملخص

Background: Dutasteride, is a drug whose mechanism of action is inhibition of the enzyme 5-alpha reductase. It has been approved for use in the treatment of benign prostatic hyperplasia. Dutasteride has low solubility and high permeability, which classifies it as Biopharmaceutics classification system class II, according to the Biopharmaceutics Classification System. It has a water solubility of only 0.038 ng/mL and a slow dissolving rate, resulting in its exclusive availability in the market as a formulation contained within soft gelatin capsules.

Objective: The aim of this study involves two parts. First, is the enhancement of dutasteride dissolution rate, by the creation of dutasteride nanosuspension, and second is the enhancement of patient compliance by the transformation of this nanosuspension to oral fast-dissolving film, which is characterized by its fast disintegration, stability, and ease of administration.

Methods: The solvent anti/solvent precipitation method was used to formulate dutasteride nanosuspension. In addition, dutasteride nanoparticles oral fast dissolving films were prepared by using the solvent casting method.

To compare the in vitro release patterns of pure dutasteride film and selected dutasteride nanoparticles film, the statistical analysis for the dissolution investigation was conducted using the model-independent technique (employing similarity factor f2) utilizing a DD solver. The selected dutasteride nanoparticle film was supposed to be the test material, while the pure dutasteride film was supposed to serve as the reference.

Results: dutasteride nanosuspension demonstrated a high enhancement of the dissolution rate. In addition, the prepared dutasteride nanoparticles oral fast-dissolving film exhibited a further increase in the rate of dissolution and fast disintegration, and the administration is easy, all of these properties making it a promising dosage form.

Conclusion: Nanosuspension is an excellent approach for enhancing the solubility, dissolution rate, and effectiveness of drugs with limited aqueous solubility such as dutasteride. In addition, the oral fast-dissolving film can be considered a promising dosage form that will increase patient compliance due to its high dissolution rate, fast disintegration, and easy administration.

التنزيلات

تنزيل البيانات ليس متاحًا بعد.

السير الشخصية للمؤلفين

Rusul W. Kadhum، Department of Pharmaceutics, College of Pharmacy, University of Babylon, Babylon, Iraq.

Department of Pharmaceutics, College of Pharmacy, University of Babylon, Babylon, Iraq.
Shaimaa N. Abd-Alhammid ، Department of Pharmaceutics, College of Pharmacy, University of Baghdad, Baghdad, Iraq.

Department of Pharmaceutics, College of Pharmacy, University of Baghdad, Baghdad, Iraq.

المراجع

Sakhri S, Gooren LJ. Safety aspects of androgen treatment with 5α-dihydrotestosterone. Andrologia. 2007; 39: 216–22. https://doi.org/10.1111/j.1439-0272.2007.00786.x.

Eun HC, Kwon OS, Yeon JH, et al. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study. J Am Acad Dermatol. 2010; 63: 252–8. https://doi.org/10.1016/j.jaad.2009.09.018

Andriole G, Bruchovsky N, Chung L. Dihydrotestosterone and the prostate: The scientific rationale for 5α-reductase inhibitors in the treatment of benign prostatic hyperplasia. J Urol. 2004; 172: 1399–403. https://doi.org/10.1097/01.ju.0000139539.94828.29.

Lee DH, Yeom DW, Song YS, Cho HR, Choi YS, Kang MJ, ChoiYW. Improved oral absorption of dutasteride via Soluplus®-based supersaturable self-emulsifying drug delivery system(S-SEDDS). International journal of pharmaceutics. 2015; 478(1):341-347. https://doi.org/10.1016/j.ijpharm.2014.11.060

Sadoon NA, Ghareeb MM. Formulation and Characterization of Isradipine as Oral Nanoemulsion . IJPS. 2020;29 (1). https://doi.org/10.31351/vol29iss1pp143-153.

Mosharraf M, Nyström C. The effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugs. International journal of pharmaceutics. 1995; 1; 122(1-2):35-47. DOI: https://doi.org/10.1016/0378-5173(95)00033-F.

Khadka P, Ro J, Kim H, Kim I, Kim JT, Kim H, Cho JM, Yun G, Lee J. Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability. Asian Journal of Pharmaceutical Sciences. 2014; 9(6): 304-316. https://doi.org/10.1016/j.ajps.2014.05.005.

Vermaa S, Lan Y, Gokhale R, Burgessa DJ. Quality by design approach to understand the process of nanosuspension preparation. Int J Pharm. 2009;377: 185-98. https://doi.org/10.1016/j.ijpharm.2009.05.006

Muhesen R A, Rajab NA. Formulation and characterization of olmesartan medoxomil as a nanoparticle. Research J. Pharm. and Tech. 2023; 16 (7): 1-7. http://dx.doi.org/10.52711/0974-360X.2023.00547.

Baek I, Kim J, Eun-Sol Ha, Gwang-Ho Choo. Dissolution and oral absorption of pranlukast nanosuspensions stabilized by hydroxypropylmethylcellulose. Int J Biol Macromol 2014; 67: 53-7. https://doi.org/10.1016/j.ijbiomac.2014.03.006.

Oudah MH, Rahi FA and Al-lami MS. Preparation and Characterization of Domperidone Nanoparticles for Dissolution Improvement. IJPS. 2018; 27 (1). https://doi.org/10.31351/vol27iss1pp39-52.

Al-Obaidy RAR, Rajab NA. Preparation and In-vitro Evaluation of Darifenacin HBr as Nanoparticles Prepared as Nanosuspension. International Journal of Drug Delivery Technology. 2022; 12(2):775-781. https://doi.org/10.25258/ijddt.12.2.55.

Patel VF, Liu F, Brown MB. Advances in oral transmucosal drug delivery. J Control Release. 2011; 153(2):106–16. https://doi.org/10.1016/j.jconrel.2011.01.027.

Takeuchi H, Yamakawa R, Nishimatsu T, Takeuchi Y, Hayakawa K, Maruyama N. Design of rapidly disintegrating drug delivery films for oral doses with hydoxypropyl methylcellulose. J Drug Deliv Sci Technol. 2013; 23(5):471–5. http://dx.doi.org/10.1016/S1773-2247(13)50068-2.

Saeed AMH, Alaayed M, Al-jarsha HYM. Effect of Natural/ Synthetic Polymers and Super disintegrants on the Formulation of Zafirlukast Fast Dissolving Film. Research Journal of Pharmacy and Technology.2022; 15(4): 1567-1572. https://doi.org/10.52711/0974-360X.2022.00261.

Goel H, Rai P, Rana V, Tiwary AK. Orally disintegrating systems: innovations in formulation and technology. Recent Pat Drug Deliv Formul 2008;2: 258–74. https://doi.org/10.2174/187221108786241660.

Liew, K. bin, Tan, Y. T. F. and Peh, K. K. 2. Effect of polymer, plasticizer and filler on orally disintegrating film. Drug Development and Industrial Pharmacy.2014; 40(1). DOI: https://doi.org/10.3109/03639045.2012.749889.

Chonkar AD, Venkat Rao JRS, Managuli RS, S Mutalik. Development of fast dissolving oral films containing lercanidipine hcl nanoparticles in the semicrystalline polymeric matrix for enhanced dissolution and ex vivo permeation. Eur J Pharm Biopharm 2016;103: 179-91. https://doi.org/10.1016/j.ejpb.2016.04.001.

Dzakwan M, Ganet EP, Rachmat M, Wikarsa S. Nanosized and enhancement of solubility fisetin. Asian Journal of Pharmaceutical Research and Development. 2019;7(2):6–10. https://doi.org/10.22270/ajprd.v7i2.465.

Abbs KI, Rajab NA. Formulation and In-Vitro Evaluation of Darifenacin Hydrobromide as Buccal Films. IJPS.2019;28(2). https://doi.org/10.31351/vol28iss2pp83-94.

Shen C, Shen B, Xu H, Bai J, Dai L, Lv Q, Han J, Yuan H. Formulation and optimization of a novel oral fast dissolving film containing drug nanoparticles by Box–Behnken design–response surface methodology. Drug development and industrial pharmacy.2014 1;40(5):649-56. https://doi.org/10.3109/03639045.2014.884116.

Shekhawat P, Pokharkar V. Risk assessment and QbD based optimization of an Eprosartan mesylate nanosuspension: In-vitro characterization, PAMPA and in-vivo assessment. Int J Pharm. 2019; 567:118415. https://doi.org/10.1016/j.ijpharm.2019.06.006

Noor AH, Ghareeb MM. Formulation and Evaluation of Ondansetron HCl Nanoparticles for Transdermal Delivery. IJPS.2020; 29 (2). https://doi.org/10.31351/vol29iss2pp70-79

Cilurzo F, Cupone IE, Minghetti P, Buratti S, Selmin F, Gennari CG, Montanari L. Nicotine Fast dissolving oral films Made of Maltodextrin. A feasibility studies. APPS Pharm Sci Tech. 2010; 11(4): 1511-1517. https://doi.org/10.1208/s12249-010-9525-6.

Sarykar M, Assaad M. Measuring perceived sweetness by monitoring sorbitol concentration in apples using a non-destructive polarization-based readout. Applied Optics. 2021; 60(19):5723-34. https://doi.org/10.1364/AO.428665

Joshi, P. et al. Formulation development and evaluation of mouth dissolving film of domperidone‟, Journal of Pharmacy and Bioallied Sciences, 4(SUPPL.),2012; 108–109. https://doi.org/10.4103/0975-7406.94159

Tamer MA, Abd-AL Hammid SHN, Ahmed B. Formulation and In-vitro evaluation of bromocriptine mesylate as fast dissolving oral film. International Journal of Applied Pharmaceutics. 2018;10(1):7-20.

http://dx.doi.org/10.22159/ijap.2018v10i1.22615.

Dasari N, Swapna, Sudhakar M. Design and evaluation of fast dissolving oral films of Zolpidem by solvent casting method.Asian Journal of Pharmaceutical Research. 2016; 6(2): 67-71.

https://doi.org/10.5958/2231-5691.2016.00012.5.

Shelke PV, Dumbare AS, Gadhave MV, Jadhav SL, Sonawane AA, Gaikwad DD. Formulation and Evaluation of Rapidly Disintegrating Film of Amlodipine Besylate. Journal of Drug Delivery & Therapeutics 2012.2(2):72-75. https://doi.org/10.22270/jddt.v2i2.85.

Jyothi Sri S, Bhikshapathi DVRN. Development and Optimization of Fast Dissolving Oral Film Containing Aripiprazole. Int. J. Pharm. Sci. Drug Res. 2017; 9(6): 327-333. https://doi.org/10.25004/IJPSDR.2017.090607.

Arpa MD, Ünükür MZ, Erim ÜC. Formulation, characterization and in vitro release studies of terbinafine hydrochloride loaded buccal films. J Res Pharm. 2021; 25(5): 667-680. https://doi.org/10.29228/jrp.58.

Avachat AM, Gujar KN, Wagh K V. Development and evaluation of tamarind seed xyloglucan-based mucoadhesive buccal films of rizatriptan benzoate. Carbohydr Polym. 2013; 91(2): 537–542. https://doi.org/10.1016/j.carbpol.2012.08.062.

Pawar R, Sharma R, Sharma P, Darwhekar GN. A review on mouth dissolving film. Journal of Drug Delivery and Therapeutics. 2019 ;9(6):206-10. https://doi.org/10.22270/jddt.v9i6.3676.

Kim MS. Influence of hydrophilic additives on the supersaturation and bioavailability of dutasteride-loaded hydroxypropyl-β-cyclodextrin nanostructures. Int J Nanomedicine. 2013; 8: 2029-39. https://doi.org/10.2147/IJN.S44795

Koland M, Sandeep VP, Charyulu NR. Fast dissolving sublingual films of ondansetron hydrochloride: effect of additives on in vitro drug release and mucosal permeation. JYP. 2010; 2(3):216-22.

https://doi.org/10.4103/0975-1483.66790.

Siddalingam R, Subramaniam P. Self-Nanoemulsifying Drug Delivery Systems of Poorly Soluble Drug Dutasteride: Formulation and In-Vitro characterization. J App Pharm Sci, 2017; 7 (04): 011- 022. https://doi.org/10.7324/JAPS.2017.70402.

Zuo J, Gao Y, Bou-Chacra N, Löbenberg R. Evaluation of the DDSolver software applications. Biomed Res Int. 2014;2014: 1-9. https://doi.org/10.1155/2014/204925.

Pathan A, Gupta MK, Jain NK, Dubey A, Agrawal A. Formulation and evaluation of fast dissolving oral film of promethazine hydrochloride using different surfactant. Development 2016; 2: 7-18.

Prabhu P, Malli R, Koland M, Vijaynarayana K, D’Souza U, Harish NM, Shastry CS, Charyulu RN. Formulation and evaluation of fast dissolving films of levocitirizine dihydrochloride. International journal of pharmaceutical investigation. 2011; 1(2):99. https://doi.org/10.4103/2230-973X.82417.

Abd-Alhammid NS, Saleeh HH. Formulation and Evaluation of Flurbiprofen Oral Film. IJPS. 2014; 23(1): 53-59. https://doi.org/10.31351/vol23iss1pp53-59.

Dasari N, Swapna, Sudhakar M. Design and evaluation of fast dissolving oral films of Zolpidem by solvent casting method. Asian Journal of Pharmaceutical Research. 2016; 6(2): 67-71.

https://doi.org/10.5958/2231-5691.2016.00012.5.

Habib BA, Abd El-Samiae AS, El-Houssieny BM, Tag R. Formulation, characterization, optimization, and in-vivo performance of febuxostat self-nano-emulsifying system loaded sublingual films. Drug Deliv .2021;28(1):1321–1333. https://doi.org/10.1080/10717544.2021

Cilurzo F, Cupone I E, Minghetti P, Selmin F, Montanari L. Fastdissolving films made of. Eur J Pharm Biopharm 2008; 895–900. https://doi.org/10.1016/j.ejpb.2008.06.032.

Taghi HS, Abdulbaqi MR, Jabar EG. Enhancement Solubilization of Dutasteride using Microsponge Formulation. International Journal of Drug Delivery Technology. 2020; 10(1): 60-67. https://doi.org/10.25258/ijddt.10.1.10

Patil SS, Patil SJ, Vakhariya RR, Chopade AR,Mohite SK.Formulation and Evaluation of Fast Dissolving Buccal Film of Curcumin as Promising Route of Buccal Delivery.Journal of University of Shanghai for Science and Technology. 2021; 23(5): 498-505. https://doi.org/10.51201/JUSST/21/05/157.

Nirmala D, Nandhini S, Sudhakar M. Design and Evaluation of Fast Dissolving Oral Films of Zolpidem by Solvent Casting Method. Asian J. Pharm. Res., 2016, 6; 67-71. https://doi.org/10.5958/2231-5691.2016.00012.5.

Pawar SV, Junagade M. Formulation and Evaluation of mouth dissolving film of risperidone. Drug Deliv Syst 2015;9: 11. URL

Patel JG, Modi AD. Formulation, optimization and evaluation of levocetirizine dihydrochloride oral thin strip. J Pharm Bioall Sci 2012;4: 35-6.https://doi.org/10.4103/0975-7406.94133.

Jyothi S, DVRN Bhikshapathi. Development and optimization of fast-dissolving oral film containing aripiprazole. Int J Pharm Sci Drug Res 2017; 9:327-33. https://doi.org/10.25004/IJPSDR.2017.090607.

Alka Tomar, Kiran Sharma, Nitesh S Chauhan, Ashu Mittal, Umakant Bajaj “Formulation and Evaluation of Fast Dissolving Oral Film of Dicyclomine as potential route of Buccal Delivery” Int. J. Drug Dev. & Res., April-June 2012, 4(2): 408-417. URL

Garsuch V, Breitkreutz J. Comparative investigations on different polymers for the preparation of fast-dissolving oral. JPP. 2010; 62: 539–545. https://doi.org/10.1211/jpp.62.04.0018.

Repka MA, Gutta K, Prodduturi S, Munjal M, Stodghill SP. Characterization of cellulosic hot-melt extruded films containing lidocaine. Euro J Pharm Biopharm 2005; 59: 189-196. https://doi.org/10.1016/j.ejpb.2004.06.008.

Jassim ZE, Mohammed, Sadeq ZA. Formulation and Evaluation of Fast-Dissolving Film of Lornoxicam. AJPCR. 2018; 11(9):217-223. https://doi.org/10.22159/ajpcr.2018.v11i9.27098.